J G Brunet1, J K Iyer1, M S Badin1, L Graf2, K A Moffat3,4, M Timleck1, E Spitzer1, C P M Hayward1,3,4. 1. Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada. 2. Centre for Laboratory Medicine and Hemophilia and Hemostasis Centre, St. Gallen, Switzerland. 3. Department of Medicine, McMaster University, Hamilton, ON, Canada. 4. Hamilton Regional Laboratory Medicine Program, Hamilton, ON, Canada.
Abstract
INTRODUCTION: Dense granule (DG) deficiency (DGD) is a feature of some platelet function disorders (PFD) with a prevalence similar to von Willebrand disease. Most laboratories assess for DGD using whole mount platelet preparations and electron microscopy (EM). We evaluated our experiences with this test and associations between DGD and bleeding. METHODS: Dense granule EM records for 2006-2017 were examined for patients and simultaneously tested controls, and for an overlapping PFD study cohort to evaluate findings and their relationship to bleeding. RESULTS: More patient than control samples had reduced DG counts (6.5% vs 0.3%, P < .01). DG counts showed no relationship to age or mean platelet volume and had acceptable within-subject variability that was higher for DGD than control participants (28% vs 12%). Repeat tests confirmed DGD in all persons with initial DG counts <4.0/platelet, but not in those with less severe reductions (4.0-4.8 DG/platelet) or normal DG counts (≥4.9 DG/platelet). Aggregometry and adenosine triphosphate release tests, respectively, had only ~52% and 70% sensitivity for DGD. Confirmed DGD by EM was associated with higher bleeding scores and a bleeding disorder. CONCLUSION: Whole mount EM is useful for the evaluation of suspected PFD due to DGD and detects abnormalities associated with bleeding.
INTRODUCTION: Dense granule (DG) deficiency (DGD) is a feature of some platelet function disorders (PFD) with a prevalence similar to von Willebrand disease. Most laboratories assess for DGD using whole mount platelet preparations and electron microscopy (EM). We evaluated our experiences with this test and associations between DGD and bleeding. METHODS: Dense granule EM records for 2006-2017 were examined for patients and simultaneously tested controls, and for an overlapping PFD study cohort to evaluate findings and their relationship to bleeding. RESULTS: More patient than control samples had reduced DG counts (6.5% vs 0.3%, P < .01). DG counts showed no relationship to age or mean platelet volume and had acceptable within-subject variability that was higher for DGD than control participants (28% vs 12%). Repeat tests confirmed DGD in all persons with initial DG counts <4.0/platelet, but not in those with less severe reductions (4.0-4.8 DG/platelet) or normal DG counts (≥4.9 DG/platelet). Aggregometry and adenosine triphosphate release tests, respectively, had only ~52% and 70% sensitivity for DGD. Confirmed DGD by EM was associated with higher bleeding scores and a bleeding disorder. CONCLUSION: Whole mount EM is useful for the evaluation of suspected PFD due to DGD and detects abnormalities associated with bleeding.
Authors: Justin Brunet; Matthew Badin; Michael Chong; Janaki Iyer; Subia Tasneem; Lucas Graf; Georges E Rivard; Andrew D Paterson; Guillaume Pare; Catherine P M Hayward Journal: Res Pract Thromb Haemost Date: 2020-05-30
Authors: Ivar van Asten; Maaike Blaauwgeers; Lianne Granneman; Harry F G Heijnen; Marieke J H A Kruip; Erik A M Beckers; Michiel Coppens; Jeroen Eikenboom; Rienk Y J Tamminga; Gerard Pasterkamp; Albert Huisman; Karin P M van Galen; Suzanne J A Korporaal; Roger E G Schutgens; Rolf T Urbanus Journal: J Thromb Haemost Date: 2019-12-27 Impact factor: 5.824
Authors: William T Gunning; Stanislaw M Stepkowski; Paula M Kramer; Beverly L Karabin; Blair P Grubb Journal: J Clin Med Date: 2021-02-06 Impact factor: 4.241
Authors: William T Gunning; Paula M Kramer; Jacob A Cichocki; Beverly L Karabin; Sadik A Khuder; Blair P Grubb Journal: Cells Date: 2022-02-23 Impact factor: 6.600
Authors: Tanmya Sharma; Justin G Brunet; Subia Tasneem; Stephanie A Smith; James H Morrissey; Catherine P M Hayward Journal: Int J Lab Hematol Date: 2021-06-29 Impact factor: 3.450